Tod Smeal
Technik-/Wissenschafts-/F&E-Leiter bei CARDIFF ONCOLOGY, INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Tod Smeal
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CARDIFF ONCOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.01.2022 | - |
Karriereverlauf von Tod Smeal
Ehemalige bekannte Positionen von Tod Smeal
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Hexagon Bio, Inc.
 Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 | 01.01.2021 |
| ELI LILLY AND COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 | 01.01.2020 |
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2003 | 01.01.2015 |
Ausbildung von Tod Smeal
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CARDIFF ONCOLOGY, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Health Technology |